AI Generated Content

This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.

Rapid Read    •   5 min read

Corewell Health and Quest Diagnostics Announce Lab Testing Joint Venture

WHAT'S THE STORY?

What's Happening?

Corewell Health and Quest Diagnostics have entered into a joint venture to manage inpatient and outpatient lab services and construct a new advanced lab facility. The agreement grants Corewell Health 49% equity and Quest Diagnostics 51% ownership. The venture aims to enhance healthcare affordability and accessibility, with the new facility supporting advanced lab technologies. Quest will manage Corewell's hospital labs, providing comprehensive diagnostic services. The facility is expected to be operational by 2027, with certain agreements starting in late 2025.
AD

Why It's Important?

This joint venture represents a strategic collaboration to improve healthcare delivery and diagnostic services. By combining Corewell Health's regional expertise with Quest Diagnostics' national capabilities, the partnership aims to expand access to high-quality lab services. The new facility will support advanced testing technologies, benefiting patients and healthcare providers. This initiative aligns with Quest's growth strategy to collaborate with top health systems, enhancing its presence in the healthcare market and driving innovation in diagnostic services.

AI Generated Content

AD
More Stories You Might Enjoy

Corewell Health and Quest Diagnostics Announce Joint Venture to Enhance Lab Testing Services

Corewell Health, a nonprofit health system with 21 hospitals, has entered into a joint venture with Quest Diagnostics to manage inpatient and outpa...

Story by Rapid Read
AD

Corewell Health and Quest Diagnostics Announce Joint Venture for Advanced Lab Facility

Corewell Health has entered into a joint venture with Quest Diagnostics to manage inpatient and outpatient lab services and construct a new advance...

Story by Rapid Read

Quest Diagnostics and Corewell Health Form Joint Venture for Michigan Lab

Quest Diagnostics has partnered with Corewell Health to establish a joint-owned laboratory in Michigan, named the Diagnostic Lab of Michigan. The f...

Story by Rapid Read

Bayer Submits 'Safer, Greener' MRI Contrast Agent for FDA Review

Bayer has filed for FDA approval of a new MRI contrast agent, gadoquatrane, which is designed to reduce the use of gadolinium, a rare earth metal a...

Story by Rapid Read
AD

Penumbra, Inc. Appoints Shruthi Narayan as Company President

Penumbra, Inc., a leading thrombectomy company, has announced the promotion of Shruthi Narayan to the position of President, effective September 1,...

Story by Rapid Read

Shilpa Medicare Partners with PPI to Establish Pharma Manufacturing Facility in Saudi Arabia

Shilpa Medicare has entered into a joint venture with PPI to establish a new pharmaceutical manufacturing facility in Saudi Arabia. The venture aim...

Story by Rapid Read

Quest Diagnostics and Corewell Health Form Joint Venture to Enhance Laboratory Services

Quest Diagnostics and Corewell Health have entered into a definitive agreement to establish a joint venture aimed at building a laboratory facility...

Story by Rapid Read
AD

FDA Grants Breakthrough Device Designation for Quest Diagnostics' Haystack MRD Test

Quest Diagnostics has received Breakthrough Device Designation from the FDA for its Haystack MRD test, designed to identify MRD-positive patients w...

Story by Rapid Read

FDA Grants Breakthrough Device Designation to Quest Diagnostics for Cancer Detection Test

Quest Diagnostics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Haystack MRD t...

Story by Rapid Read

FDA Grants Breakthrough Designation to Quest Diagnostics' Haystack MRD Test

Quest Diagnostics has received Breakthrough Device Designation from the FDA for its Haystack MRD test, which identifies MRD-positive patients with ...

Story by Rapid Read
AD